Lack of association between increased carotid intima-media thickening and decreased HDL-cholesterol in a family with a novel ABCA1 variant, G2265T

Clinical Chemistry

Volumn 48, Issue 11, 2002, Pages 2066-2070

  Hong, Seung Ho ^a   Riley, Ward ^a   Rhyne, Jeffrey ^a   Friel, Gina ^a   Miller, Michael ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FAMILY; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; PEDIGREE;

EID: 0036827972     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.11.2066     Document Type: Article

References (29)

1. Miller M, Mead L, Kwiterovich PO, Pearson TA. Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease. Am J Cardiol 1990;65:1-5.
2. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999;104:R25-31.
3. Brook-Wilson A, Marcil M, Clee SM, Zhang L-H, Roomp K, van Dam M, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336-45.
4. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999;22:347-51.
5. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999;22:352-5.
6. Rader DJ, Ikewaki K, Duverger N, Feuerstein I, Zech L, Connor W, et al. Very low high-density lipoproteins without coronary atherosclerosis. Lancet 1993;342:1455-8.
7. Schaefer EJ, McNamara JR, Mitri CJ, Ordovas JM. Genetic high density lipoprotein deficiency states and atherosclerosis. Adv Exp Med Biol 1986;201:1-15.
8. Wang J, Burnett JR, Near S, Young K, Zinman B, Hanley AJG, et al. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol 2000;20:1983-9.
9. Marcil M, Broooks-Wilson A, Clee SM, Roomp K, Zhang L-H, Yu L, et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet 1999;354:1341-6.
10. Pullinger CR, Hakamata H, Duchateau PN, Eng C, Aouizert BE, Cho MH, et al. Analysis of hABC1 gene 5′ end: Additional peptide sequence, promoter region, and four polymorphisms. Biochem Biophys Res Commun 2000;271:451-5.
11. Hong SH, Rhyne J, Zeller K, Miller M. Novel ABCA1 compound variant associated with HDL deficiency. Biochim Biophys Acta 2002;21;1587:60-4.
12. Miller M, Aiello D, Pritchard H, Friel G, Zeller K. Apolipoprotein A-I (Zavalla) (Leu159→Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease. Arterioscler Thromb Vasc Biol 1998;18:1242-7.
13. Kasid A, Rhyne J, Zeller K, Pritchard H, Miller M. A novel TC deletion resulting in Pro(260)→Stop in the human LCAT gene is associated with a dominant effect on HDL-cholesterol. Atherosclerosis 2001;156:127-32.
14. Gotoda T, Yamada N, Kawamura M, Kozaki K, Mori N, Ishibashi S, et al. Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest 1991;88:1856-64.
15. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999;19:1734-43.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000;102:1503-10.
18. Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J. The molecular pathology of lecithin:Cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 1997;38:191-205.
19. Serfaty-Lacrosniere C, Civeira F, Lanzberg A, Isaia P, Berg J, Janus ED, et al. Homozygous Tangier disease and cardiovascular disease, Atherosclerosis 1994;107:85-98.
20. Milano mutant: The Limone sul Garda Study. Circulation 2001;103:1949-54.
21. Baldassarre D, Amato M, Pustina L, Tremoli E, Sirtori CR, Calabresi L, et al. Increased carotid artery intima-media thickness in subjects with primary hypoalphalipoproteinemia. Arterioscler Thromb Vasc Biol 2002;22:317-22.
22. van Dam MJ, de Groot E, Clee SM, Hovingh GK, Roelants R, Brooks-Wilson A, et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: An observational study. Lancet 2002;359:37-42.
23. Attie AD, Kastelein JP, Hayden MR. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res 2001;42:1717-26.
24. Schmitz G, Langmann T. Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol 2001;12:129-40.
25. Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, Freeman MW. Naturally occurring mutations in ABCA1's largest extracellular loops can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 2002;Jun 25 [epub ahead of print].
26. Lewis RA, Shroyer NF, Singh N, Allikmets R, Hutchinson A, Li Y, et al. Genotype/phenotype analysis of a photoreceptor-specific ATP-binding Cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet 1999;64:422-34.
27. Bertolini S, Pisciotta L, Seri M, Cusano R, Cantafora A, Calabresi L, et al. A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease. Atherosclerosis 2001;154:599-605.
28. Clee SM, Kastelein JJP, van Dam M, Marcil M, Roomp K, Zwarts KY, et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 2000;106:1263-70.
29. Schmitz G, Langmann T, Heimer S. Role of ABCG1 and other ABCG family members in lipid metabolism. J Lipid Res 2001;42:1513-20.